TABLE OF CONTENTS
Volume 26, Issue 12 (15 March 2007)
Original Articles
Normal cellular senescence and cancer susceptibility in mice genetically deficient in Ras-induced senescence-1 (Ris1)
M Nieto, M Barradas, L M Criado, J M Flores, M Serrano and E Llano
Oncogene 26: 1673-1680; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209978
Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway
C G Concannon, B F Koehler, Claus Reimertz, B M Murphy, C Bonner, N Thurow, M W Ward, A Villunger, A Strasser, D Kögel and J H M Prehn
Oncogene 26: 1681-1692; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209974
MUC1 is a novel regulator of ErbB1 receptor trafficking
M R Pochampalli, R M el Bejjani and J A Schroeder
Oncogene 26: 1693-1701; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209976
Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice
M Pérez-Caro, N Gutierrez-Cianca, I González-Herrero, I López-Hernández, T Flores, A Orfao, M Sánchez-Martín, A Gutiérrez-Adán, B Pintado and I Sánchez-García
Oncogene 26: 1702-1713; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209968
PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors
A M Deshpande, J D Akunowicz, X T Reveles, B B Patel, E A Saria, R G Gorlick, S L Naylor, R J Leach and M F Hansen
Oncogene 26: 1714-1722; advance online publication, September 25, 2006; doi:10.1038/sj.onc.1209988
Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis
P Rojas, M B Cadenas, P-C Lin, F Benavides, C J Conti and M L Rodriguez-Puebla
Oncogene 26: 1723-1730; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209970
RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation
F Rinaldo, J Li, E Wang, M Muders and K Datta
Oncogene 26: 1731-1738; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209971
Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130
D C Mitchell, L J Stafford, D Li, M Bar-Eli and M Liu
Oncogene 26: 1739-1747; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209963
Mechanism of ASC-mediated apoptosis: Bid-dependent apoptosis in type II cells
M Hasegawa, K Kawase, N Inohara, R Imamura, W-C Yeh, T Kinoshita and T Suda
Oncogene 26: 1748-1756; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209965
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
S C Gamble, D Chotai, M Odontiadis, D A Dart, G N Brooke, S M Powell, V Reebye, A Varela-Carver, Y Kawano, J Waxman and C L Bevan
Oncogene 26: 1757-1768; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209967
WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential
F Reiter, M Hartl, A I Karagiannidis and K Bister
Oncogene 26: 1769-1779; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209975
HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion
C M Karp, M N Shukla, D J Buckley and A R Buckley
Oncogene 26: 1780-1788; advance online publication, September 25, 2006; doi:10.1038/sj.onc.1209980
Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBP
by inhibiting its ubiquitination
A K Trivedi, D Bararia, M Christopeit, A A PeerZada, S M Singh, A Kieser, W Hiddemann, H M Behre and G Behre
Oncogene 26: 1789-1801; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209964
Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter
R Kikuchi, M Murakami, S Sobue, T Iwasaki, K Hagiwara, A Takagi, T Kojima, H Asano, M Suzuki, Y Banno, Y Nozawa and T Murate
Oncogene 26: 1802-1810; advance online publication, September 11, 2006; doi:10.1038/sj.onc.1209973
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis
B Liu, K-W Lee, M Anzo, B Zhang, X Zi, Y Tao, L Shiry, M Pollak, S Lin and P Cohen
Oncogene 26: 1811-1819; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209977
Short Communication
The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity
M Thullberg, A Gad, A Beeser, J Chernoff and S Strömblad
Oncogene 26: 1820-1828; advance online publication, September 25, 2006; doi:10.1038/sj.onc.1209983
